:: Main :: About :: Current Issue :: Archive :: Submit :: Contact ::
:: Volume 6, Issue 2 (12-2019) ::
vacres 2019, 6(2): 1-8 Back to browse issues page
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
Nada Abdel Aziz , Hatem Tallima , Marwa Abou El Dahab, Rashika El Ridi *
Zoology Department, Faculty of Science, Cairo University
Abstract:   (610 Views)
Introduction: Vaccination of hamsters with Schistosoma mansoni adjuvant-free recombinant cathepsin B1 (SmCB1) and L3 (SmCL3) have been shown to elicit highly significant (P < 0.005) protection against challenge Schistosoma haematobium that was not very superior to that achieved by the cysteine peptidase, papain.  Sterilizing immunity might, however, be induced if hamsters were vaccinated against S. haematobium infection with a homologous cysteine peptidase, i.e., S. haematobium cathepsin L (ShCL).   Methods: Standards methods, techniques, and primers based on the published nucleotide sequence of ShCL were used to clone, amplify and express DNAs encoding the target enzyme in a bacterial expression vector.  Repeat immunization trials were performed using recombinant ShCL alone or in combination with the vaccine candidate S. mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase, in parallel with S. mansoni lecucine aminopeptidase.  Results: The results together indicated that our adjuvant-free, cysteine peptidase-based vaccine elicits highly significant (P < 0.0001) reduction in challenge worm burden and parasite egg viability.  Protection was associated with whole blood cultures release of type 1, type 2, and type 17 cytokines, and modest, yet significant (P < 0.05) humoral response to ShCL.  Conclusion: Sterilizing immunity was, however, not achieved in any trial, likely because of the preponderant role of cysteine peptidases-induced nonspecific factors in amplifying and antagonizing its protective potential.  Experiments are planned in an aim to identify these elusive factors and their exact role.
Keywords: |Schistosoma haematobium|Hamsters|Cysteine peptidases|Vaccine|Worm burden|Oogram ,
Full-Text [PDF 562 kb]   (144 Downloads)    
Type of Study: Original article | Subject: Vaccine development, efficacy and safety evaluation
Received: 2020/01/15 | Accepted: 2020/05/16 | Published: 2020/06/28
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abdel Aziz N, Tallima H, Abou El Dahab M, El Ridi R. Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium. vacres. 2019; 6 (2) :1-8
URL: http://vacres.pasteur.ac.ir/article-1-164-en.html

Volume 6, Issue 2 (12-2019) Back to browse issues page
Vaccine Research Vaccine Research
Persian site map - English site map - Created in 0.12 seconds with 31 queries by YEKTAWEB 4247
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.